A demand spike during the pandemic prompted manufacturers to buy sketchy components, putting themselves at legal risk.

Johnson & Johnson has wasted no time expanding its portfolio. In the past two years it has invested more than $60 billion into research and development (R&D), as well as mergers and acquisitions, ...